1. Antibodies against the c-terminus of apoA-1 as predictors of death in the general population but not as therapeutic targets actionable through cognate peptides immunomodulation. (25th November 2020) Authors: Vuilleumier, N; Antiochos, P; Marques Vidal, P; Virzi, J; Pagano, S; Satta, N; Hartley, O; Brandt, K; Burger, F; Montecucco, F; Kutalik, Z; Waeber, G; Mach, F; Vollenweider, P Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Autoantibodies directed against apolipoprotein A-1 as a potential contributor to non-alcoholic fatty liver disease. (14th October 2021) Authors: Pagano, S; Alfaiate, D; Juillard, C; Frias, M; Magenta, A; Martino, F; Sciaqua, A; Succurro, E; Burger, F; Brandt, K J; Andreozzi, F; Mach, F; Perticone, M; Vuilleumier, N Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phenotypic variation of tuberous sclerosis in a single extended kindred. Issue 10 (October 1994) Authors: Smalley, S L; Burger, F; Smith, M Journal: Journal of medical genetics Issue: Volume 31:Issue 10(1994) Page Start: 761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗